Xiaobing Ju
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Renal cell carcinoma treatment
- Renal and Vascular Pathologies
Papers in
-
- RNA modifications and cancer 5
- Renal and related cancers 5
-
- Renal cell carcinoma treatment 12
- Renal and Vascular Pathologies 7
- Co-authors
- Changjun Yin (34 shared papers)Chao Qin (32 shared papers)Xiaoxin Meng (29 shared papers)Pengfei Shao (25 shared papers)Qiang Cao (25 shared papers)Pu Li (22 shared papers)Qiang Lv (7 shared papers)Hongzhou Cai (10 shared papers)
- Journals
- PLoS ONE (6 papers)Renal Failure (5 papers)European Urology (4 papers)Urology (3 papers)Frontiers in Genetics (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobing Ju
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 418
- Pulmonary and Respiratory Medicine 494
- Molecular Biology 720
- Transplantation 25
- Urology 54
Countries citing papers authored by Xiaobing Ju
This map shows the geographic impact of Xiaobing Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Ju more than expected).
Fields of papers citing papers by Xiaobing Ju
This network shows the impact of papers produced by Xiaobing Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Ju. The network helps show where Xiaobing Ju may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobing Ju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 124 | |
| 2 | 2012 | 81 | |
| 3 | 2013 | 67 | |
| 4 | 2014 | 63 | |
| 5 | 2015 | 58 | |
| 6 | 2013 | 54 | |
| 7 | 2013 | 51 | |
| 8 | 2012 | 48 | |
| 9 | 2012 | 43 | |
| 10 | 2014 | 43 | |
| 11 | 2012 | 43 | |
| 12 | 2016 | 36 | |
| 13 | 2018 | 28 | |
| 14 | 2010 | 27 | |
| 15 | 2014 | 26 | |
| 16 | 2012 | 26 | |
| 17 | 2013 | 26 | |
| 18 | 2021 | 26 | |
| 19 | 2022 | 24 | |
| 20 | 2013 | 22 |
About Xiaobing Ju
Xiaobing Ju is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Oncology, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), MicroRNA in disease regulation (9 papers), Renal Transplantation Outcomes and Treatments (8 papers), Renal and Vascular Pathologies (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers), Renal and related cancers (5 papers) and Parathyroid Disorders and Treatments (5 papers). The work is most often cited by research in Cancer Research (418 citations), Pulmonary and Respiratory Medicine (494 citations), Molecular Biology (720 citations), Transplantation (25 citations) and Urology (54 citations). Xiaobing Ju has collaborated with scholars based in China and United States. Frequent co-authors include Changjun Yin, Chao Qin, Xiaoxin Meng, Pengfei Shao, Qiang Cao, Pu Li, Qiang Lv, Hongzhou Cai, Zhengdong Zhang and Meilin Wang. Their work appears in journals such as PLoS ONE, Renal Failure, European Urology, Urology and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.